Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Not applicableStudy completedNCT04151849
What this trial is testing

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Who this might be right for
Type 2 Diabetes
University of Tartu 23
Large-scale testing (Phase 3)WithdrawnNCT02229240
What this trial is testing

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Post-approval studies (Phase 4)Study completedNCT03361098
What this trial is testing

DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2

Who this might be right for
Type 2 Diabetes MellitusObesity
Amsterdam UMC, location VUmc 65
Not applicableEnded earlyNCT06273163
What this trial is testing

Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation

Who this might be right for
Obesity
University of Texas Southwestern Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00571324
What this trial is testing

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

Who this might be right for
Congenital Hyperinsulinism
Diva De Leon 9
Not applicableNot Yet RecruitingNCT07783113
What this trial is testing

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

Who this might be right for
Alopecia
Farmoquimica S.A. 48
Testing effectiveness (Phase 2)Study completedNCT02541734
What this trial is testing

Effect of Gelofusine on GLP1-receptor Imaging

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus
Radboud University Medical Center 12
Not applicableStudy completedNCT06500130
What this trial is testing

Effects of Liraglutide on Body Surface Gastric Mapping

Who this might be right for
GastroparesisFunctional DyspepsiaChronic Nausea and Vomiting Syndrome+1 more
Alimetry 22
Post-approval studies (Phase 4)Not Yet RecruitingNCT07775846
What this trial is testing

QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Kidney Disease
Huijie Zhang 820
Large-scale testing (Phase 3)Study completedNCT04537923
What this trial is testing

Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 1,428
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Early research (Phase 1)UnknownNCT06562088
What this trial is testing

A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 40
Not applicableLooking for participantsNCT07743567
What this trial is testing

Gestational Response, Outcomes, and Weight After GLP-1 Use

Who this might be right for
Pregnant IndividualsObesity & OverweightGestational Weight Gain
University of Kansas Medical Center 400
Not applicableStudy completedNCT07623148
What this trial is testing

GLP-1 RA Cessation and Gastric Ultrasound Findings

Who this might be right for
Residual Gastric ContentsDelayed Gastric Emptying
Wonkwang University Hospital 186
Not applicableNot Yet RecruitingNCT07687667
What this trial is testing

Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS)ObesityInfertility, Female
Peking University Third Hospital 406
Large-scale testing (Phase 3)Active Not RecruitingNCT06162715
What this trial is testing

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Who this might be right for
Severe ObesityObesityBMI Greater Than 30
Vanderbilt University Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07336862
What this trial is testing

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

Who this might be right for
Obesity
China-Japan Friendship Hospital 200
Next Page